Wall Street brokerages expect that CME Group Inc (NASDAQ:CME) will report sales of $910.75 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for CME Group’s earnings, with the lowest sales estimate coming in at $889.00 million and the highest estimate coming in at $940.70 million. CME Group reported sales of $912.90 million in the same quarter last year, which indicates a negative year over year growth rate of 0.2%. The firm is expected to announce its next quarterly earnings results before the market opens on Thursday, February 1st.

On average, analysts expect that CME Group will report full year sales of $910.75 million for the current year, with estimates ranging from $3.63 billion to $3.68 billion. For the next fiscal year, analysts anticipate that the firm will post sales of $3.91 billion per share, with estimates ranging from $3.79 billion to $3.99 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. CME Group’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.05 EPS.

A number of analysts have issued reports on CME shares. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target on the stock in a research note on Tuesday. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Citigroup boosted their price target on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. Royal Bank of Canada boosted their price target on shares of CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research note on Monday, October 16th. Finally, Barclays boosted their price target on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 10th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. CME Group currently has an average rating of “Buy” and an average target price of $144.22.

Shares of CME Group (NASDAQ CME) traded up $0.97 on Wednesday, reaching $149.65. 947,362 shares of the company traded hands, compared to its average volume of 1,510,000. The stock has a market cap of $51,260.00, a price-to-earnings ratio of 33.93, a P/E/G ratio of 2.62 and a beta of 0.72. CME Group has a 12-month low of $113.90 and a 12-month high of $155.29. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05.

The business also recently disclosed a dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Thursday, December 28th will be given a dividend of $3.50 per share. The ex-dividend date is Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s payout ratio is currently 59.86%.

In other news, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total transaction of $722,947.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jack J. Tobin sold 2,325 shares of the business’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $152.28, for a total value of $354,051.00. Following the transaction, the insider now directly owns 17,574 shares of the company’s stock, valued at $2,676,168.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 37,603 shares of company stock valued at $5,456,551. Corporate insiders own 0.57% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Fiduciary Trust Co. acquired a new position in CME Group in the second quarter valued at approximately $105,000. Valeo Financial Advisors LLC acquired a new position in CME Group in the third quarter valued at approximately $124,000. Quadrant Capital Group LLC boosted its holdings in CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA acquired a new position in CME Group in the second quarter valued at approximately $129,000. Finally, People s United Financial Inc. boosted its holdings in CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares in the last quarter. 82.70% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Zacks: Brokerages Expect CME Group Inc (CME) Will Post Quarterly Sales of $910.75 Million” was first reported by Marea Informative and is the property of of Marea Informative. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.mareainformativa.com/2018/01/29/zacks-brokerages-expect-cme-group-inc-cme-will-post-quarterly-sales-of-910-75-million-updated-updated-updated.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.